Cargando…
Predicting miRNA targets for hepatocellular carcinoma with an integrated method
BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algori...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798414/ https://www.ncbi.nlm.nih.gov/pubmed/35117522 http://dx.doi.org/10.21037/tcr.2020.02.46 |
_version_ | 1784641800307212288 |
---|---|
author | Shi, Yi-Hua Wen, Tian-Fu Xiao, De-Shuang Dai, Ling-Bo Song, Jun |
author_facet | Shi, Yi-Hua Wen, Tian-Fu Xiao, De-Shuang Dai, Ling-Bo Song, Jun |
author_sort | Shi, Yi-Hua |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algorithm was applied to combine a correlation method (Pearson’s correlation coefficient, PCC), a causal inference method (IDA), and a regression method (Lasso) to generate an integrated method. Subsequently, to confirm the performance of the integrated method, the predicted miRNA targets results were compared with the confirmed database. Finally, pathway enrichment analysis was applied to evaluate the target genes in the top 1,000 miRNA-messenger RNA (mRNA) interactions. RESULTS: The method was confirmed to be an approach to predict miRNA targets. Moreover, 50 highly confident miRNA-mRNA interactions were obtained, including 6 miRNA targets with predicted times ≥10 (for instance, MEG3). The 860 target genes of the top 1,000 miRNA-mRNA interactions were enriched in 26 pathways, of which complement and coagulation cascades were most significant. CONCLUSIONS: The results might supply great insights for revealing the pathological mechanism underlying HCC and explore potential biomarkers for the diagnosis and treatment of this tumor. However, these biomarkers have not been confirmed, and the related validations should be performed in future studies. |
format | Online Article Text |
id | pubmed-8798414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87984142022-02-02 Predicting miRNA targets for hepatocellular carcinoma with an integrated method Shi, Yi-Hua Wen, Tian-Fu Xiao, De-Shuang Dai, Ling-Bo Song, Jun Transl Cancer Res Original Article BACKGROUND: MicroRNAs (miRNAs) were aberrantly regulated in cancers, showing their roles as novel classes of oncogenes and tumor suppressors. Hence, an integrated method was introduced in this study to explore miRNA targets for hepatocellular carcinoma (HCC). METHODS: The Borda count election algorithm was applied to combine a correlation method (Pearson’s correlation coefficient, PCC), a causal inference method (IDA), and a regression method (Lasso) to generate an integrated method. Subsequently, to confirm the performance of the integrated method, the predicted miRNA targets results were compared with the confirmed database. Finally, pathway enrichment analysis was applied to evaluate the target genes in the top 1,000 miRNA-messenger RNA (mRNA) interactions. RESULTS: The method was confirmed to be an approach to predict miRNA targets. Moreover, 50 highly confident miRNA-mRNA interactions were obtained, including 6 miRNA targets with predicted times ≥10 (for instance, MEG3). The 860 target genes of the top 1,000 miRNA-mRNA interactions were enriched in 26 pathways, of which complement and coagulation cascades were most significant. CONCLUSIONS: The results might supply great insights for revealing the pathological mechanism underlying HCC and explore potential biomarkers for the diagnosis and treatment of this tumor. However, these biomarkers have not been confirmed, and the related validations should be performed in future studies. AME Publishing Company 2020-03 /pmc/articles/PMC8798414/ /pubmed/35117522 http://dx.doi.org/10.21037/tcr.2020.02.46 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Original Article Shi, Yi-Hua Wen, Tian-Fu Xiao, De-Shuang Dai, Ling-Bo Song, Jun Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title | Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title_full | Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title_fullStr | Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title_full_unstemmed | Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title_short | Predicting miRNA targets for hepatocellular carcinoma with an integrated method |
title_sort | predicting mirna targets for hepatocellular carcinoma with an integrated method |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798414/ https://www.ncbi.nlm.nih.gov/pubmed/35117522 http://dx.doi.org/10.21037/tcr.2020.02.46 |
work_keys_str_mv | AT shiyihua predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod AT wentianfu predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod AT xiaodeshuang predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod AT dailingbo predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod AT songjun predictingmirnatargetsforhepatocellularcarcinomawithanintegratedmethod |